Search research articles
Contact Us
Filters
Showing results (71-80 of 75) with videos related to
Page
of 8
Sort By:
You have reached the last page of results.
This site can display upto 75 results.
ACS Applied Bio Materials
|
May 4, 2026
Dendronized Polymeric Biomaterial for Loading, Stabilization, and Targeted Cytosolic Delivery of microRNA in Cancer Cells
Vishakha Tambe, Sagarkumar Patel, Amit Shard, et al.
Current Medicinal Chemistry
|
September 9, 2020
Current Scenario and Future Prospect in the Management of COVID-19
Pobitra Borah, Pran Kishore Deb, Satyendra Deka, et al.
International Journal of Nanomedicine
|
November 6, 2019
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy
Nagaraja SreeHarsha, Rahul Maheshwari, Bandar E Al-Dhubiab, et al.
Drug Discovery Today
|
December 27, 2016
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
Jennifer M Wickens, Hashem O Alsaab, Prashant Kesharwani, et al.
Tuberculosis (Edinburgh, Scotland)
|
September 21, 2020
Current advances in the clinical development of anti-tubercular agents
Samanvai Reddy Tetali, Eswar Kunapaeddi, Raghu Prasad Mailavaram, et al.
Page
of 8
Search research articles
Search
Showing results (71-80 of 75) with videos related to
Sort By:
Page
of 8
You have reached the last page of results.
This site can display upto 75 results.
ACS Applied Bio Materials
|
May 4, 2026
Dendronized Polymeric Biomaterial for Loading, Stabilization, and Targeted Cytosolic Delivery of microRNA in Cancer Cells
Vishakha Tambe, Sagarkumar Patel, Amit Shard, et al.
Current Medicinal Chemistry
|
September 9, 2020
Current Scenario and Future Prospect in the Management of COVID-19
Pobitra Borah, Pran Kishore Deb, Satyendra Deka, et al.
International Journal of Nanomedicine
|
November 6, 2019
Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy
Nagaraja SreeHarsha, Rahul Maheshwari, Bandar E Al-Dhubiab, et al.
Drug Discovery Today
|
December 27, 2016
Recent advances in hyaluronic acid-decorated nanocarriers for targeted cancer therapy
Jennifer M Wickens, Hashem O Alsaab, Prashant Kesharwani, et al.
Tuberculosis (Edinburgh, Scotland)
|
September 21, 2020
Current advances in the clinical development of anti-tubercular agents
Samanvai Reddy Tetali, Eswar Kunapaeddi, Raghu Prasad Mailavaram, et al.
Page
of 8